Tue, 21-Oct-2025

Pfizer has stopped enrolling in the Paxlovid experiment

Paxlovid

The study finds drugs not effective in reducing symptoms in standard-risk patients. The drug has emergency use authorization for high-risk groups. Data from Israel shows drug reduces hospitalization and death rates in vaccinated and unvaccinated patients 65 years and older, but was not found to prevent severe illness. Pfizer Inc (PFE.N) said on Tuesday it … Read more

IPR violations cause significant revenue loss: OICCI survey

OICCI

KARACHI: A majority of respondents in the Overseas Investors Chamber of Commerce and Industry (OICCI) survey, indicated that it takes 1 to 3 years to resolve a standard intellectual property rights (IPR) dispute. The OICCI has announced the key findings of its latest IPR survey 2021 where 37 per cent of the respondents indicated that … Read more

Regular tea drinkers have healthier brains: Research

Regular tea drinkers have healthier brains

Regular tea drinkers have better organized brain regions—something associated with healthy cognitive function—compared to non-tea drinkers, according to new research. According to World Economic Forum, “Our results offer the first evidence of positive contribution of tea drinking to brain structure, and suggest that drinking tea regularly has a protective effect against age-related decline in brain … Read more